Literature DB >> 9310004

Spiking Survanta with synthetic surfactant peptides improves oxygenation in surfactant-deficient rats.

F J Walther1, J Hernández-Juviel, R Bruni, A J Waring.   

Abstract

The hypothesis that the in vivo function of Survanta (Beractant) can be improved by supplementation with synthetic surfactant peptides B and C was tested in a surfactant-deficient rat model. Full length surfactant protein-B (SP-B1-78) (B) and palmitoylated surfactant protein-C (SP-C1-35) (C), and synthetic KL4 peptide were added to Survanta after extraction, creating extracted Survanta (ES) with 1% B, 2% B, and 2% B plus 1% C, or mixed with Survanta without extraction, creating modified Survanta (S) with 2% B, 2% B plus 1% C, and 2% KL4. Adult rats were ventilated with 100% oxygen, tidal volumes (VT) of 7.5 ml/kg and a rate of 60/min, and were lavaged until the PaO2 dropped below 80 mm Hg, when 100 mg/kg of surfactant was instilled. After 15 to 60 min of ventilation, pressure-volume (P-V) curves were generated in situ. Instillation of ES or S with 2% B plus 1% C led to the greatest increase in oxygenation, closely followed by ES and S with 2% B, and more distantly by S plus 2% KL4. TLC was comparable among the ES and S groups, but greater than that of air-placebo controls. These data suggest that spiking of Survanta with synthetic SP-B and SP-C increased oxygenation more effectively than B or KL4 alone in this surfactant-deficient rat model.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9310004     DOI: 10.1164/ajrccm.156.3.9611053

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  12 in total

1.  More than a monolayer: relating lung surfactant structure and mechanics to composition.

Authors:  Coralie Alonso; Tim Alig; Joonsung Yoon; Frank Bringezu; Heidi Warriner; Joseph A Zasadzinski
Journal:  Biophys J       Date:  2004-09-28       Impact factor: 4.033

2.  Function and inhibition sensitivity of the N-terminal segment of surfactant protein B (SP-B1-25) in preterm rabbits.

Authors:  M Gupta; J M Hernandez-Juviel; A J Waring; F J Walther
Journal:  Thorax       Date:  2001-11       Impact factor: 9.139

3.  Effects of lung surfactant proteins, SP-B and SP-C, and palmitic acid on monolayer stability.

Authors:  J Ding; D Y Takamoto; A von Nahmen; M M Lipp; K Y Lee; A J Waring; J A Zasadzinski
Journal:  Biophys J       Date:  2001-05       Impact factor: 4.033

Review 4.  Surfactant therapy for acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; D Willson; R H Notter
Journal:  Crit Care Clin       Date:  2011-07       Impact factor: 3.598

5.  Synchrotron X-ray study of lung surfactant-specific protein SP-B in lipid monolayers.

Authors:  K Y Lee; J Majewski; T L Kuhl; P B Howes; K Kjaer; M M Lipp; A J Waring; J A Zasadzinski; G S Smith
Journal:  Biophys J       Date:  2001-07       Impact factor: 4.033

Review 6.  Pharmacotherapy of acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; Gloria S Pryhuber; Patricia R Chess; Bruce A Davidson; Paul R Knight; Robert H Notter
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

Review 7.  Surfactant for pediatric acute lung injury.

Authors:  Douglas F Willson; Patricia R Chess; Robert H Notter
Journal:  Pediatr Clin North Am       Date:  2008-06       Impact factor: 3.278

8.  Effect of hydrophobic surfactant proteins SP-B and SP-C on binary phospholipid monolayers: II. Infrared external reflectance-absorption spectroscopy.

Authors:  Jennifer M Brockman; Zhengdong Wang; Robert H Notter; Richard A Dluhy
Journal:  Biophys J       Date:  2003-01       Impact factor: 4.033

9.  Pathophysiological Approaches of Acute Respiratory Distress syndrome: Novel Bases for Study of Lung Injury.

Authors:  R L Castillo; R Carrasco Loza; C Romero-Dapueto
Journal:  Open Respir Med J       Date:  2015-06-26

Review 10.  Animal models of acute lung injury.

Authors:  Gustavo Matute-Bello; Charles W Frevert; Thomas R Martin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-07-11       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.